跳至主要内容
临床试验/JPRN-UMIN000044807
JPRN-UMIN000044807已完成未知

Prospective observation study for combination therapy of Docetaxel and Ramucirumab after immunochemotherapy in advanced non-small cell lung cancer patients - Prospective observation study for combination therapy of Docetaxel and Ramucirumab after immunochemotherapy in advanced non-small cell lung cancer patients

Kyoto Prefectural University of Medicine0 个研究点目标入组 44 人开始时间: 2021年7月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with a history of treatment with systemic chemotherapy after combination therapy with immune checkpoint inhibitors and chemotherapy 2) Patients with active multiple cancers (hormone therapy for prostate cancer and breast cancer is acceptable) (3)Other patients who are deemed inappropriate by the physician in charge

研究者

相似试验